This inventor holds 1 USPTO granted patent. Top assignee: Pantec Biosolutions Ag. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Dorothea Terhorst: Innovator in Laser-Assisted Vaccine Administration
Introduction
Dorothea Terhorst is an accomplished inventor based in Marseilles, France, known for her significant contributions to the field of medical technology, particularly in vaccine delivery systems. With one patent to her name, her work has the potential to revolutionize how vaccines are administered, enhancing both efficacy and patient comfort.
Latest Patents
Terhorst's notable patent is for a technology designed for the "Laser-assisted intradermal administration of active substances." This innovative approach involves the use of laser-generated micropores to deliver vaccine preparations comprising an antigen, linked to a binder of a dermal migratory antigen-presenting cell (APC). The invention not only covers the vaccination process but also includes pharmaceutical preparations aimed at regional delivery to targeted locations. Furthermore, it addresses the laser-assisted administration of antigens alongside repeated chemotherapy, showcasing the versatility and significant implications of her invention.
Career Highlights
Dorothea Terhorst's career is marked by her dedication to advancing medical treatment methodologies. She is currently associated with Pantec Biosolutions AG, a company that focuses on developing innovative solutions for drug delivery. Her work at Pantec has been pivotal in enhancing the effectiveness of intradermal vaccine administration, thus contributing to better healthcare outcomes.
Collaborations
Throughout her career, Terhorst has worked alongside esteemed colleagues, including Reinhard Braun and Sandrine Henri. These collaborations have fostered a multidisciplinary approach to her research and development efforts, enabling the integration of various expertise in the innovation of medical technologies.
Conclusion
Dorothea Terhorst's contributions to the field of vaccine administration are significant and reflect her commitment to improving healthcare methodologies. With her innovative patent and collaboration with notable professionals, she continues to make strides in the development of more effective and less invasive medical treatments. Her work holds promise for the future of vaccine delivery, benefiting both patients and healthcare providers alike.